GBM is a highly heterogeneous tumour consisting of mutant cells that share many antigens such as GFAP with neural stem cells (NSCs), NSC-derived astrocytes and oligodendrocyte precursor cells (OPCs) [59] making it difficult to distinguish from astrocytic cells by the use of antibodies. This evidence concerns the gene GFAP and neoplasm.